| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Feb 14, 2026 | Tax withholding(F) | 579 | $1.63 | $944 | 314K |
| Feb 14, 2026 | Tax withholding(F) | 1K | $1.63 | $2K | 2.1M |
Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-26-000934) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Acrivon Therapeutics, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.